Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer
      QxMD      Google Scholar   
Citation:
JAMA vol 307 (13) 1383-1393
Year:
2012
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pmc-release
Note:
401 is parent abstract
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
1
Parents:
401   405   570   2552  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
CA37377, CA-37404, N01 CA032102, U10 CA021115, U10 CA012027, U10 CA180835, CA12027, U10 CA031946, CA-14028, U10 CA037404, U24 CA114740, U10 CA014028, CA-114740, CA-35103, CA-25224, U10 CA035272, CA49957, CA-35113, CA-32102, U10 CA032102, U10 CA035113, CA-35272, U10 CA049957, CA21115, U10 CA025224, CA31946, U10 CA037377, U10 CA035103  
Corr. Author:
 
Authors:
                                     
Primary Study
N0147
Secondary Studies:
Phases:
3
Keywords:
Article